Reference values for lower-limb strength in people on hemodialysis
Official title: Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)
Run by Cardenal Herrera University · NCT07642778 · Data updated 2026-11-12
This study tests typical lower-leg and hip-strength values in people with chronic kidney disease who are on hemodialysis to help clinicians understand what is normal for this group.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Cardenal Herrera University Academic / other |
| Locations | 1 site (Madrid) |
| Status | Recruiting |
| Started | October 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT07642778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults on hemodialysis for at least one month, able to understand assessments and without major lower-limb disabilities or unstable severe comorbidities.
✕Probably not a fit
Patients with recent major cardiac events, severe lower-limb impairment, or inability to participate in assessments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study seeks to establish reference values for lower-limb dynamometry in adults with CKD undergoing hemodialysis. It builds on prior work showing intradialytic measurement of hip flexion and abduction is feasible and safe, with the goal of defining normative benchmarks for this population. The project considers the logistical challenges of testing during dialysis sessions and aims to provide interpretable strength data to support functional assessment. No interventions are applied beyond measurement, and eligibility requires being on dialysis for at least one month and able to understand the assessments. Data collection occurs at collaborating centers in Madrid and Potsdam to capture diverse patient experiences.
Why it matters
Potential benefit: If successful, the study could provide clinicians with reference values to better interpret muscle strength tests in dialysis patients and guide rehabilitation planning.
How similar studies have gone: Preliminary work has shown intradialytic strength measurements are safe and reliable, but population-specific reference values are still needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥1 months on HD (3 weekly sessions of 4 hours) Exclusion Criteria: * Lower-limb amputation; * Neurological, musculoskeletal or osteoarticular disorders; * Severe/unstable comorbidities (e.g., decompensated heart failure or diabetes, unstable angina, recent MI, uncontrolled hypertension, severe lung disease, acute infection); * \<1 months on HD; * \<2 sessions/week, * Inability to understand assessments.
Where it's running
-
Diaverum Madrid
Madrid, Spain Recruiting
Study contacts
- Study coordinator: Eva Ms Segura Ortí, Professor
- Email: esegura@uchceu.es
- Phone: +34671580094
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Amino acid–only IDPN for adults on dialysis with malnutrition
This study looks back at medical records to see if giving a 7.2% amino acid solution during dialysis helps nutritional status in adults with chronic kidney disease on maintenance hemodialysis.
-
Exercise programs during hemodialysis to improve function and quality of life
This study tests whether aerobic cycling or elastic-band resistance exercise during hemodialysis is safe and helpful for adults on maintenance dialysis.
-
Carotid ultrasound wall texture to identify cardiovascular risk in Type 2 diabetes
This project will test whether carotid ultrasound measurements, including intima-media thickness and layer-specific wall texture, can help predict 10-year heart risk in adults aged 40–69 with Type 2 diabetes.
-
How GLP‑1 receptor agonists affect unhealthy organ fat in people with chronic kidney disease
This observational project will test whether taking GLP‑1 receptor agonist medicines changes harmful fat around organs and related inflammation in adults with chronic kidney disease who also have obesity or type 2 diabetes.
-
MI Paste Plus for lowering Streptococcus mutans and preventing white spot lesions during fixed orthodontic treatment
This trial will test whether daily application of MI Paste Plus reduces Streptococcus mutans levels and prevents white spot lesions in people aged 5–45 who wear fixed braces.
-
Delirium Zero protocol to prevent delirium after hip fracture surgery
This trial will try whether a family-led Delirium Zero protocol (orientation poster, wall clock, and a caregiver checklist) can prevent delirium in people over 65 having hip fracture surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.